Welcome to LookChem.com Sign In|Join Free
  • or
N-ethyl-4,5-difluoro-2-nitroaniline is an organic compound with the chemical formula C8H8F2N2O2. It is a derivative of aniline, featuring a nitro group at the 2-position, two fluorine atoms at the 4 and 5 positions, and an ethyl group at the nitrogen atom. This yellow crystalline solid is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals, particularly in the production of certain herbicides and insecticides. Due to its reactivity and potential toxicity, it is important to handle N-ethyl-4,5-difluoro-2-nitroaniline with care, following appropriate safety protocols.

1736-92-1

Post Buying Request

1736-92-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1736-92-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1736-92-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,3 and 6 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1736-92:
(6*1)+(5*7)+(4*3)+(3*6)+(2*9)+(1*2)=91
91 % 10 = 1
So 1736-92-1 is a valid CAS Registry Number.

1736-92-1Relevant academic research and scientific papers

METALLOENZYME INHIBITOR COMPOUNDS

-

Paragraph 0394; 0395; 0396; 0397, (2018/07/29)

Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

METALLOENZYME INHIBITOR COMPOUNDS

-

Paragraph 0542; 0543; 0544; 0545, (2018/07/29)

Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES

-

Page/Page column 25, (2009/10/22)

The present invention relates to quinoxalinone derivatives of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as defined in claim 1, as insulin secretion stimulators. The invention also relates to the preparation and use of these quinoxalinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated. Other preferred compounds are compounds of general formula (I), wherein R1, R2, R3, R4, R5 and R6 can be optionally substituted by one or more groups selected from Z.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1736-92-1